Related Experiment Video

Updated: Apr 9, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.5K

Neonatal drug therapy: The first frontier of therapeutics for children

K Allegaert1,2, J van den Anker3,4,5,6

  • 1Neonatal Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.

Clinical Pharmacology and Therapeutics
|June 23, 2015
PubMed

Insights

Despite advances, neonatal medicine use has few label changes. A newborn-driven research agenda is needed to address unique pediatric clinical needs and diseases.

Area of Science:

  • Neonatal pharmacology
  • Pediatric drug development

Background:

  • Knowledge on safe and effective neonatal medication use has grown significantly.
  • However, this has led to minimal changes in drug labeling for newborns.
  • Adult medications are often adapted for neonatal use, but this approach may not fully meet infants' specific needs.

Purpose of the Study:

  • To highlight the need for a shift in neonatal pharmacotherapy.
  • To advocate for a research agenda tailored to the specific clinical requirements of neonates.
  • To emphasize the importance of addressing unique neonatal diseases.

Main Methods:

  • Review of current practices in neonatal drug utilization.
  • Analysis of the gap between adult-derived and neonate-specific therapeutic needs.
  • Conceptual framework for developing a newborn-driven research agenda.

Main Results:

  • Substantial increase in knowledge regarding neonatal medicine safety and efficacy.
  • Limited translation of this knowledge into updated drug labels.
  • Prevalence of adapting adult drugs versus developing neonate-specific treatments.

Conclusions:

  • Current approaches to neonatal pharmacotherapy require re-evaluation.
  • Collaborative networks are essential for establishing a newborn-driven research agenda.
  • Addressing the distinct clinical needs and diseases of neonates is paramount for improving their therapeutic outcomes.

More Related Videos

Intravenous Injections in Neonatal Mice05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

62.3K
A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

7.3K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
383
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
842
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
489
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
786
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K